Summary
Signal counts
Assets tracked: 2
Watchlist assets: 2
Registry stop assets: 1
Sponsor overview
Zhejiang Cancer Hospital
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT01258192 | https://clinicaltrials.gov/study/NCT04084158
Assets
Linked programs
- albumin-bound paclitaxel plus cisplatin: Results Not Found Signal (2/5)
- Toripalimab injection (JS001): Registry Stop Signal (4/5)